Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib
| Image |  |
|---|---|
| Description | scientific article published on 17 July 2017 |
| Author/s |
author: David G. Maloney John C. Byrd |
| Publication date | July 17, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |